The results from a 48-week phase 2 trial in patients with obesity who are at risk of developing cardiovascular diseases, showed that patients had achieved a mean weight loss of 15.6% on a 2.4 mg dose of the drug, and notably, improvements in blood pressure as well as no cardiac event imbalances took place
[36], it was found that the expression of genes involved in oxidative phosphorylation was downregulated in CD4+ T cells in the blood of HS patients, suggesting a metabolic shift towards glycolysis in HS
Serving Size: 1 capsule Amount Per Serving: SAMe (S-adenosylmethionine) (from S-adenosyl-L-methionine disulfate tosylate)
That's been very helpful for a variety of things from post-viral with the pandemic, had a lot of success with BPC, to, again, you name it
Related products Go to Top